Literature DB >> 30230924

Barriers to accurately assessing prescription opioid misuse on surveys.

Joseph J Palamar1.   

Abstract

Surveys are the leading method of gathering data on prevalence and correlates of prescription opioid misuse. As the opioid crisis continues in the United States, reliable data on misuse have become increasingly important as under- and overreporting is common. This perspective discusses six potential barriers to researchers accurately assessing opioid misuse on surveys. These barriers include lack of respondent drug knowledge, researchers not properly defining opioids for respondents, querying overall opioid misuse rather than misuse of specific opioids, varying terminology (e.g., of opioids and misuse), and lack of understanding of medical versus nonmedical use or misuse. Finally, a recent barrier is use of counterfeit or adulterated drugs that contain fentanyl, its analogs, or other new synthetic opioids, which can lead to underreporting of exposure. Survey researchers should consider such barriers when querying opioid misuse.

Entities:  

Keywords:  Opioids; data collection; epidemiology; measurement error; survey methods

Year:  2018        PMID: 30230924      PMCID: PMC6424651          DOI: 10.1080/00952990.2018.1521826

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  33 in total

1.  Non-medical use of prescription opioids during the transition to adulthood: a multi-cohort national longitudinal study.

Authors:  Sean Esteban McCabe; John E Schulenberg; Patrick M O'Malley; Megan E Patrick; Deborah D Kloska
Journal:  Addiction       Date:  2013-10-22       Impact factor: 6.526

2.  Discrepancies in prevalence estimates in two national surveys for nonmedical use of a specific opioid product versus any prescription pain reliever.

Authors:  Gabriella Biondo; Howard D Chilcoat
Journal:  Drug Alcohol Depend       Date:  2013-10-24       Impact factor: 4.492

Review 3.  The validity of self-reported drug use in survey research: an overview and critique of research methods.

Authors:  L Harrison
Journal:  NIDA Res Monogr       Date:  1997

4.  Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.

Authors:  Daniel Ciccarone; Jeff Ondocsin; Sarah G Mars
Journal:  Int J Drug Policy       Date:  2017-07-18

5.  Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada.

Authors:  Benedikt Fischer; Anca Ialomiteanu; Angela Boak; Edward Adlaf; Jürgen Rehm; Robert E Mann
Journal:  Drug Alcohol Rev       Date:  2013-01-11

6.  Adverse Effects From Counterfeit Alprazolam Tablets.

Authors:  Ann M Arens; Xander M R van Wijk; Kathy T Vo; Kara L Lynch; Alan H B Wu; Craig G Smollin
Journal:  JAMA Intern Med       Date:  2016-10-01       Impact factor: 21.873

7.  Fatal Fentanyl: One Pill Can Kill.

Authors:  Mark E Sutter; Roy R Gerona; M Thais Davis; Bailey M Roche; Daniel K Colby; James A Chenoweth; Axel J Adams; Kelly P Owen; Jonathan B Ford; Hugh B Black; Timothy E Albertson
Journal:  Acad Emerg Med       Date:  2016-10-31       Impact factor: 3.451

8.  Rapid Change in Fentanyl Prevalence in a Community-Based, High-Risk Sample.

Authors:  Andrea A Jones; Kerry Jang; William J Panenka; Alasdair M Barr; G William MacEwan; Allen E Thornton; William G Honer
Journal:  JAMA Psychiatry       Date:  2018-03-01       Impact factor: 21.596

9.  Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors.

Authors:  Joseph J Palamar; Jenni A Shearston; Charles M Cleland
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-17       Impact factor: 3.829

10.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults.

Authors:  Beth Han; Wilson M Compton; Carlos Blanco; Christopher M Jones
Journal:  Ann Intern Med       Date:  2018-03-06       Impact factor: 25.391

View more
  6 in total

1.  Construction trade and extraction workers: A population at high risk for drug use in the United States, 2005-2014.

Authors:  Danielle C Ompad; Robyn R Gershon; Simon Sandh; Patricia Acosta; Joseph J Palamar
Journal:  Drug Alcohol Depend       Date:  2019-10-30       Impact factor: 4.492

2.  What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates.

Authors:  Natalie S Levy; Joseph J Palamar; Stephen J Mooney; Charles M Cleland; Katherine M Keyes
Journal:  Ann Epidemiol       Date:  2022-01-03       Impact factor: 6.996

3.  Underreporting of drug use on a survey of electronic dance music party attendees.

Authors:  Joseph J Palamar; Austin Le
Journal:  Addict Res Theory       Date:  2019-08-20

4.  Underreporting of drug use among electronic dance music party attendees.

Authors:  Joseph J Palamar; Alberto Salomone; Katherine M Keyes
Journal:  Clin Toxicol (Phila)       Date:  2020-07-09       Impact factor: 4.467

5.  Reliability of a Rapid Screener for an Intercept Survey about Drug Use.

Authors:  Joseph J Palamar; Patricia Acosta; Charles M Cleland; Scott Sherman
Journal:  Subst Use Misuse       Date:  2021-07-27       Impact factor: 2.362

6.  A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.

Authors:  Francisco A Montiel Ishino; Philip R McNab; Tamika Gilreath; Bonita Salmeron; Faustine Williams
Journal:  BMC Public Health       Date:  2020-11-18       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.